Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
St Pharm CoXKRX:237690 +0.87%96 OCF Margin % is 1.91% as of Jun. 2026, which is 56% below its 10-year median of 4.31. GuruFocus rates XKRX:237690 with a GF Score™ of 96/100 and a GF Value™ of ₩115,775.72 (Modestly Undervalued). Among 987 Drug Manufacturers companies, St Pharm Co ranks better than 90.58% on this metric.
The historical rank and industry rank for St Pharm Co's OCF Margin % or its related term are showing as below:
XKRX:237690'
s OCF Margin % Range Over the Past 10 Years
Min: -32.72 Med: 4.31 Max: 39.98
Current: 29.72
During the past 13 years, the highest OCF Margin % of St Pharm Co was 39.98%. The lowest was -32.72%. And the median was 4.31%.
XKRX:237690's OCF Margin % is ranked better than 90.58% of 987
companies
in the Drug Manufacturers industry
Industry Median: 9.81
vs XKRX:237690: 29.72
The historical data trend for St Pharm Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, St Pharm Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
St Pharm Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, St Pharm Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where St Pharm Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
St Pharm Co (XKRX:237690) has a OCF Margin % of 1.91% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on St Pharm Co and its competitors. This is 56% below median its historical median of 4.31. According to the industry distribution chart, St Pharm Co ranks #93 out of 987 companies in the Drug Manufacturers industry, placing it in the top 9.4%.
Is St Pharm Co's OCF Margin % too high?
St Pharm Co's current OCF Margin % of 1.91% is 56% below median its 10-year median of 4.31. The Drug Manufacturers industry median OCF Margin % is 9.81. St Pharm Co's value of 1.91% is 80.5% below this industry median. Based on the distribution chart, St Pharm Co ranks #93 out of 987 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, St Pharm Co has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does St Pharm Co's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, St Pharm Co ranks #93 out of 987 companies for OCF Margin %. This places St Pharm Co in the top 9% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.81. St Pharm Co's value of 1.91% is 80.5% below this benchmark. While the company's 10-year median is 4.31 vs. the industry median of 9.81, St Pharm Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.81, based on 987 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. St Pharm Co's current OCF Margin % of 1.91% is 80.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on St Pharm Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. St Pharm Co's current OCF Margin % is 1.91%, which is 56% below median its own 10-year median of 4.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is St Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, St Pharm Co (XKRX:237690) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩115,775.72, compared to a current price of ₩92,700.00 — trading 19.9% below its estimated fair value. The current OCF Margin % is 1.91%, which is 56% below median its 10-year median of 4.31 and 80.5% below the Drug Manufacturers industry median of 9.81. St Pharm Co's overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For St Pharm Co (XKRX:237690), the current OCF Margin % is 1.91% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is St Pharm Co (XKRX:237690) Overvalued in 2026?
Based on GuruFocus' analysis, St Pharm Co stock appears to be undervalued.
The current stock price of ₩92,700.00 is trading 19.9% below its estimated GF Value™ of ₩115,775.72.
GuruFocus considers St Pharm Co to be Modestly Undervalued.
Key valuation signals for XKRX:237690:
OCF Margin %: 1.91% (56% below median its 10-year median of 4.31)
GF Value™: ₩115,775.72 vs. price of ₩92,700.00 (19.9% below fair value)
Industry Position: 80.5% below the Drug Manufacturers median (#93 of 987)
No single metric tells the full story. See the XKRX:237690 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, requirements. The firm's business areas include commercial manufacturing of new drug development, manufacturing of generic active pharmaceutical ingredients, fine chemical's business and development of oligonucleotide therapeutics. The company's products comprise small molecule active pharmaceutical ingredients, Anti-cancer, Anti- coagulant active pharmaceutical ingredients, etc.
96GF Score
Get the complete analysis for XKRX:237690
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:237690 has been successfully added to your 
